Vaccines can be made over 25% more effective by adding left-handed chiral gold nanoparticles as adjuvants, according to a study by an international collaboration in...
Since the onset of the Coronavirus Disease 2019 (COVID-19) pandemic, it has brought about episodic waves of increased infections due to the emergence of new severe...
The genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is about 80% similar to that of SARS-CoV. This high degree of similarity shared...
Using soluble spike (S) protein as bait, several separate investigations have isolated anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific B cells from those infected or those...
Most antibiotics are double-edged swords. Besides killing the pathogen they are prescribed for, they also decimate beneficial bacteria and change the composition of the gut...
A recent study posted to the bioRxiv* preprint server investigated the active genetic evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro),...
In a recent study published in the journal PLOS Genetics, researchers explored severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) ribonucleic acid (RNA) editing in host cells....
In a recent Pathogens review article, researchers discuss the development and structural characterization of therapeutic monoclonal antibodies targeting the surface glycoprotein of filoviruses, including the...
A recent study published in PLOS ONE analyzed the polymorphisms in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) proteins’ S1/S2 subunits. Study:...
In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that envelope (E) proteins of β-coronaviruses (CoVs) could restrict human immunodeficiency virus type 1...
A recent study published in the PeerJ journal identified unique truncated open reading frame 8 (ORF8) proteins among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
A recent study posted to the Research Square* server characterized the genetic and immunological aspects of the infectious bronchitis virus (IBV) vaccines commercially used in...
